|
⚲
|
| Keyboard |
| Actuate Therapeutics Inc | |
|---|---|
| Ticker | ACTU |
| CIK # | 0001652935 |
| CUSIP | 005083100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1751 River Run Suite 400, Fort Worth, TX 76107 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Actuate Therapeutics Inc | 2025-07-07 | 4.7 M | Exemption: 506(b) · Remaining: $4,665,479 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001652935] | 10-K | |
| [0001652935] | 10-Q | |
| [0001652935] | 3 | |
| [0001652935] | 4 | |
| [0001652935] | 8-K | |
| [0001652935] | D | |
| [0001652935] | SC 13D | |
| [0001652935] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Voss Capital LP | Actuate Therapeutics Inc | [2025-12-17] | 0.0 |
| BIOS Fund I LP | Actuate Therapeutics Inc | [2024-08-19] | 2.8 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Schmitt Daniel M
Restricted Stock Units · derivative
|
2026-02-13 | Option exercise | 272,055 | $0.00 | |
|
Schmitt Daniel M
Common Stock
|
2026-02-13 | Tax withheld | 121,874 | $4.33 | 527,714 |
|
Schmitt Daniel M
Common Stock
|
2026-02-13 | Option exercise | 272,055 | $0.00 | |
|
Kairos Venture Partners II LP +1
Common Stock
|
2026-01-05 | Sell | 280,000 | $5.80 | 1,624,000 |
|
BIOS Fund III QP LP +9
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Bios 2024 Co-Invest LP +3
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
BIOS Fund II LP +9
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
BIOS Fund III QP LP +9
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
BIOS Fund II LP +9
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Bios 2024 Co-Invest LP +3
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Sawhney Roger
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Ronneberg Amy L
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Zabrowski Dan
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Fletcher Aaron GL
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Thomson Todd S
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Keyes Jason A
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Mazar Andrew Paul
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 51,046 | $0.00 | |
|
Mazar Andrew Paul
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 110,346 | $0.00 | |
|
Schmitt Daniel M
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 204,285 | $0.00 | |
|
Schmitt Daniel M
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 66,503 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 61 | 13,857,770 |
| 2025-12-31 | 45 | 13,110,357 |
| 2025-09-30 | 43 | 12,028,695 |
| 2025-06-30 | 38 | 11,217,557 |
| 2025-03-31 | 26 | 10,401,592 |
| 2024-12-31 | 20 | 10,116,136 |
| 2024-09-30 | 11 | 382,167 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Gleason Group Inc | [2026-06-30] | SOLE | 0 | 19,028 |
| Sowell Financial Services LLC | [2026-06-30] | SOLE | 10,973 | 10,973 |
| Green Ridge Wealth Planning LLC | [2026-06-30] | SOLE | 10,000 | 10,000 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 73 | 73 |
| Gamma Investing LLC | [2026-06-30] | DFND | 65 | 65 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 46 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 30 | 30 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 29 | Prev | Page 1 | Next |